FDA Warning Letter — Dextrum Laboratories

Case 666442 — FEI 3003092372

The FDA took a Warning Letter action against Dextrum Laboratories on Dec 7, 2023 (Miami, FL). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Dextrum Laboratories
Date
Dec 7, 2023
Fiscal Year
2024
Product Type
Drugs
Center
CDER
Location
Miami, FL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.